A macrocyclic gadolinium contrast agent bearing an assembly-dissociable feature with albumin for enhanced magnetic resonance imaging and in vivo profiles
Abstract
A novel macrocyclic GBCA, namely Gd-IN-DO3A, was designed, which exhibits an assembly-dissociable feature with HSA at Sudlow site II via moderate non-covalent interactions. The HSA-adducts ensure enhanced T 1 -weighted MRI and favorable in vivo profiles.
Fields of Study & Subjects
Lanthanide and Transition Metal Complexes
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Publication details
- Journal / source
- Journal of Materials Chemistry B
- Volume
- 14
- Issue
- 8
- Pages
- 2495–2505
- Publication date
- 1 January 2026
- Language
- EN